Cancer Genetics Inc (NASDAQ:CGIX)

1.05
Delayed Data
As of 3:59pm ET
 +0.0856 / +8.92%
Today’s Change
0.82
Today|||52-Week Range
4.35
-43.48%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Quarter 1
2018
Operating ActivitiesNet Income / Starting Line-2.8M-633.0K-7.9M-4.5M
 
 
 
 
 
Depreciation530.0K523.0K495.0K564.0K
 
 
 
 
 
Total Other Cash Flow180.0K-1.6M4.0M31.0K
 
 
 
 
 
Funds From Operations-2.1M-1.7M-3.4M-3.9M
 
 
 
 
 
Funds From/For Other Operating Expenses2.9M1.1M-118.0K611.0K
 
 
 
 
 
Net Cash Flow - Operating Activities-5.0M-2.9M-3.3M-4.5M
 
 
 
 
 
 
InvestingIncrease In Investments-200.0K0.00-50.0K0.00
 
 
 
Decrease In Investments0.000.0050.0K0.00
 
 
Capital Expenditures-222.0K-792.0K-92.0K-221.0K
 
 
 
 
 
Net Assets From Acquisitions 0.00-656.0K-435.0K0.00
 
 
 
Net Cash Flow Investing-454.0K-1.5M-630.0K-253.0K
 
 
 
 
 
 
FinancingShort Term Borrowings----------
Long Term Borrowings2.0M0.002.1M0.00
 
 
 
Long Term Debt Reduction-67.0K-69.0K-60.0K-713.0K
 
 
 
 
 
Net Proceeds Stock Sale25.0K3.0M6.6M0.00
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends----------
Cash Dividends Paid - Total0.00----0.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing2.0M3.0M8.7M-713.0K
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-------32.0K
 
 
 
Net Change In Cash-3.5M-1.4M4.7M-5.4M